Skip to main content
Journal cover image

Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.

Publication ,  Journal Article
Dressman, HK; Bild, A; Garst, J; Harpole, D; Potti, A
Published in: Curr Oncol Rep
July 2006

Despite major developments in targeted biologic agents, patients with advanced non-small-cell lung cancer have a poor prognosis. Recent development of targeted biologic agents have given us insight into possibilities of matching therapy with disease; however, the success of these agents has been marginal. In this article, we discuss the use of genomic signatures that have been developed to identify unique aspects of individual lung tumors and provide insight on how novel strategies can be used to identify populations susceptible to specific targeted agents.

Duke Scholars

Published In

Curr Oncol Rep

DOI

ISSN

1523-3790

Publication Date

July 2006

Volume

8

Issue

4

Start / End Page

252 / 257

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neoplasm Proteins
  • Lung Neoplasms
  • Humans
  • Gene Expression Profiling
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dressman, H. K., Bild, A., Garst, J., Harpole, D., & Potti, A. (2006). Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies. Curr Oncol Rep, 8(4), 252–257. https://doi.org/10.1007/s11912-006-0029-1
Dressman, Holly K., Andrea Bild, Jennifer Garst, David Harpole, and Anil Potti. “Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.Curr Oncol Rep 8, no. 4 (July 2006): 252–57. https://doi.org/10.1007/s11912-006-0029-1.
Dressman HK, Bild A, Garst J, Harpole D, Potti A. Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies. Curr Oncol Rep. 2006 Jul;8(4):252–7.
Dressman, Holly K., et al. “Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.Curr Oncol Rep, vol. 8, no. 4, July 2006, pp. 252–57. Pubmed, doi:10.1007/s11912-006-0029-1.
Dressman HK, Bild A, Garst J, Harpole D, Potti A. Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies. Curr Oncol Rep. 2006 Jul;8(4):252–257.
Journal cover image

Published In

Curr Oncol Rep

DOI

ISSN

1523-3790

Publication Date

July 2006

Volume

8

Issue

4

Start / End Page

252 / 257

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neoplasm Proteins
  • Lung Neoplasms
  • Humans
  • Gene Expression Profiling
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis